The evolving role of ctDNA in colorectal cancer: guidance of adjuvant therapy or surveillance strategies?

By afschroeder • February 13, 2026

Barrett LG, Gangi A, Hendifar A, Osipov A, Atkins K, Zaghiyan K, Nasseri Y, Murrell Z, Waters K, Mehta P, Zell JA, Hitchins MP, Gong J. The evolving role of ctDNA in colorectal cancer: guidance of adjuvant therapy or surveillance strategies? Transl Gastroenterol Hepatol. 2026 Jan 23;11:2. doi: 10.21037/tgh-25-75. PMID: 41675310; PMCID: PMC12887280.

Tags: adjuvant chemotherapy (ACT), Cedars Sinai DoM, circulating tumor DNA (ctDNA), Colon cancer, Hematology/Oncology, minimal residual disease (MRD), Publications

A Porcine Model of Intervertebral Disc Injury Recapitulates Human Discogenic Pain Via Notochordal Cell Loss and Pain-Inducing Nucleus Pulposus Cell Emergence

Kaneda G, Wechsler JT, Chavez M, Sheyn J, Cheema K, Shen C, Rigo De Righi D, Wang L, Hsu YC, Avalos P, Xie Y, Tawackoli[...]

Integrating Natural Language Processing With ChatGPT to Improve Quality of Artificial Intelligence Summaries of Prostate Cancer Consultations

Friedrich NA, Das SK, Luu M, Daniels JP, Heard J, Barsegyan A, Freedland SJ, Spiegel B, Kokorowski PK, Gonzalez Hernandez G, Daskivich TJ. Integrating Natural[...]

Clinical Triage of Individuals With Warning Symptoms of Imminent Cardiac Arrest

Reinier K, Chugh H, Kadiyala V, Sargsyan A, Uy-Evanado A, Nakamura K, Heckard E, Mathias M, Grogan T, Elashoff D, Salvucci A, Jui J, Chugh[...]